Prior to joining Goodwin, Dr. JnBaptiste conducted postdoctoral research at the Koch Institute for Integrative Cancer Research at MIT, where he performed CRISPR/Cas9 screens to identify genes important for tumorigenesis. During that time, he was also part of a multi-disciplinary team of biologists and engineers, that won a $300,000 grant to fund research and development of a novel microfluidic device for early detection and prevention of leukemia.
Dr. JnBaptiste’s doctoral research focused on the deregulation of microRNAs and embryonic gene expression networks in cancer. He has co-authored multiple peer-reviewed publications in internationally recognized journals such as Genes & Development, Genome Research and Cell Reports. Dr. JnBaptiste has given invited talks and presented posters at international and national conferences including RNA Silencing Keystone Symposia and the annual meeting of the American Society of Biochemistry and Molecular Biology.